Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC

NCT04161352 · clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Zhejiang Cancer Hospital